ICUI
ICU Medical, Inc. · Healthcare · Medical - Instruments & Supplies
动量输入(同类管理人):
持有人广度 +11.8% ·
股份流向 +3.0% ·
净新建仓位 +5.3%
— 公式
广泛积累 — 持股数量上升且持有人增多
所有持股数据:仅限已追踪的 13F 管理人,普通股持仓,报告期 Q3 2025
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 101 | +1 | 16.65M | $2.44B | +7 | −7 |
| Q1 2026 | 104 | -4 | 18.58M | $2.40B | +5 | −10 |
| Q4 2025 | 108 | +2 | 19.90M | $2.83B | +3 | — |
| Q3 2025 | 19 | +2 | 11.89M | $1.43B | +3 | −2 |
| Q2 2025 | 15 | -1 | 9.62M | $1.27B | — | −1 |
| Q1 2025 | 13 | +1 | 2.74M | $379.97M | +2 | −1 |
| Q4 2024 | 12 | 0 | 3.47M | $538.76M | — | — |
| Q3 2024 | 11 | -2 | 3.16M | $575.79M | — | −2 |
| Q2 2024 | 13 | — | 2.88M | $341.58M | — | — |
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 3.52M | -1.2% | $422.45M | 0.0% | ▼ Trim | 2 | SEC ↗ ×14 |
| 2 | The Vanguard Group ✦ (被动) | 2.62M | -1.3% | $314.89M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 3 | JPMorgan Chase ✦ | 1.35M | — | $162.27M | 0.0% | n/c | 1 | SEC ↗ ×12 |
| 4 | Millennium Management ✦ | 1.09M | +173.4% | $130.64M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 5 | State Street Global Advisors ✦ (被动) | 917.12K | -1.1% | $110.02M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 6 | Geode Capital Management ✦ (被动) | 593.33K | -1.8% | $71.19M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 7 | Morgan Stanley ✦ | 565.19K | — | $67.80M | 0.0% | n/c | 1 | SEC ↗ ×9 |
| 8 | Fidelity (FMR) ✦ | 365.28K | -19.0% | $43.82M | 0.0% | ▼ Trim | 2 | SEC ↗ ×4 |
| 9 | Goldman Sachs Group ✦ | 278.71K | — | $33.43M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 10 | Wellington Management ✦ | 237.79K | +75.6% | $28.53M | 0.0% | ▲ Add | 6 | SEC ↗ ×4 |
| 11 | Adage Capital Partners ✦ | 119.86K | 新增 | $14.38M | 0.0% | New | 1 | SEC ↗ |
| 12 | Renaissance Technologies ✦ | 69.40K | -19.9% | $8.33M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 13 | Point72 Asset Management ✦ | 51.90K | -86.4% | $6.23M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 14 | Gotham Asset Management ✦ | 41.04K | +41.4% | $4.92M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 15 | GAMCO Investors ✦ | 25.06K | +2.4% | $3.01M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 16 | T. Rowe Price ✦ | 22.98K | +5.6% | $2.76M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 8.74K | +1.9% | $1.05M | 0.0% | ▲ Add | 6 | SEC ↗ ×5 |
| 18 | Arrowstreet Capital ✦ | 3.46K | 新增 | $415,661 | 0.0% | New | 1 | SEC ↗ |
| 19 | Marshall Wace ✦ | 2.54K | 新增 | $304,698 | 0.0% | New | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Adage Capital Partners | $14.38M | 0.0% |
| Arrowstreet Capital | $415,661 | 0.0% |
| Marshall Wace | $304,698 | 0.0% |
已清仓
| Norges Bank | $36.63M | 曾为 0.0% |
| D. E. Shaw & Co. | $7.45M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构(SEC结构化数据, Q1 2026): 273 持有人, 24.54M 股份, $3.09B 已申报. 这是与上方被追踪全域数据不同的较早期间,两者从不混用。
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数,而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Officer · 724 股 · $122,736
Officer · 2.20K 股 · $369,203
Officer · 1.24K 股 · $208,523
Officer · 692 股 · $118,688
Officer · 6.38K 股 · $1.12M
Officer · 4.57K 股 · $792,291
Officer · 1.71K 股 · $292,843
Officer · 1.91K 股 · $329,443
Officer · 1.11K 股 · $193,567
Officer · 5.42K 股 · $982,265
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论